Clinical Trials Directory

Trials / Completed

CompletedNCT03482557

Contrast Enhanced Spectral Mammography vs. MRI for Breast Cancer Screening

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
132 (actual)
Sponsor
Beth Israel Deaconess Medical Center · Academic / Other
Sex
Female
Age
30 Years – 110 Years
Healthy volunteers
Not accepted

Summary

This research study is evaluating whether contrast enhanced mammography can be used as an alternative to breast Magnetic Resonance Imaging (MRI) for cancer screening

Detailed description

Mammography is the main way to help find breast cancers early so they can be treated. Unfortunately, mammography does not work as well in women who have dense breast tissue or who are at high-risk for breast cancer. In these women, breast MRI is also used to help find breast cancers. Contrast enhanced mammography is a new type of mammogram. It uses contrast material combined with the mammogram to highlight areas that might be breast cancer and that could be missed on the mammogram alone. This is similar to breast MRI. For this study, participants who had both CEM and MRI evaluating a finding that initiated from a screening exam will be included. Radiologists will compare the images to see if the contrast enhanced mammograms and the breast MRI find the same number of breast cancers. If the investigators find they perform similarly, then contrast mammography may be used to aid in breast cancer screening in the future.

Conditions

Interventions

TypeNameDescription
DEVICECESMContrast enhanced mammography is a new type of mammogram. It uses contrast material combined with the mammogram to highlight areas that might be breast cancer and that could be missed on the mammogram alone
DEVICEMRIMRI uses magnets to create a detailed image of the tissues and bones inside of the body

Timeline

Start date
2018-05-17
Primary completion
2023-08-30
Completion
2023-08-30
First posted
2018-03-29
Last updated
2025-01-09
Results posted
2025-01-09

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03482557. Inclusion in this directory is not an endorsement.